What are the clinical manifestations and treatment of a doxepin overdose?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: December 17, 2025View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

Doxepin Overdose: Clinical Manifestations and Management

Critical Manifestations

Doxepin overdose presents with life-threatening cardiac dysrhythmias, severe hypotension, convulsions, and CNS depression including coma, with toxicity developing rapidly and requiring immediate hospital monitoring. 1

Cardiovascular Manifestations

  • Cardiac dysrhythmias are the most critical feature, with QRS widening on ECG being the most clinically significant indicator of tricyclic antidepressant toxicity 1
  • Severe hypotension develops due to alpha-adrenergic blockade and direct myocardial depression 1
  • QRS duration ≥0.10 seconds on maximal limb-lead ECG is the best indication of overdose severity 1
  • Fatal dysrhythmias can occur late after overdose, even in patients who initially appeared stable 1

Neurological Manifestations

  • CNS depression progressing to coma is a dominant feature, with prolonged toxic coma possible lasting 5-7 days before return of consciousness 1, 2
  • Seizures occur and require immediate control 1
  • Confusion, disturbed concentration, and transient visual hallucinations are common 1
  • Agitation, hyperactive reflexes, stupor, drowsiness, and muscle rigidity may be present 1
  • Dilated pupils occur due to anticholinergic effects, though transient anisocoria has been reported 1, 2

Other Clinical Features

  • Vomiting is common 1
  • Hypothermia or hyperpyrexia may develop 1
  • Anticholinergic syndrome: dry mouth, urinary retention, decreased bowel sounds, hyperthermia 1

Immediate Management Algorithm

Step 1: Stabilization and Monitoring (First Priority)

  • Obtain ECG immediately and initiate continuous cardiac monitoring for minimum 6 hours, extended if any signs of toxicity appear 1
  • Protect airway, establish IV access, and prepare for intubation - early intubation is advised in patients with CNS depression due to potential for abrupt deterioration 1
  • Monitor for CNS/respiratory depression, hypotension, cardiac dysrhythmias, conduction blocks, and seizures 1

Step 2: Gastrointestinal Decontamination

  • Perform large volume gastric lavage followed by activated charcoal in all suspected cases 1
  • Secure airway prior to lavage if consciousness is impaired 1
  • Emesis is contraindicated 1

Step 3: Cardiovascular Management

  • Administer IV sodium bicarbonate to maintain serum pH 7.45-7.55 for QRS widening or dysrhythmias 1, 3
  • If pH response inadequate, add hyperventilation with extreme caution and frequent pH monitoring (avoid pH >7.60 or pCO2 <20 mmHg) 1
  • For dysrhythmias unresponsive to sodium bicarbonate, use lidocaine, bretylium, or phenytoin 1
  • Type 1A and 1C antiarrhythmics (quinidine, disopyramide, procainamide) are contraindicated 1
  • Sodium bicarbonate readily corrects potentially life-threatening cardiac arrhythmias and is imperative in treatment 3

Step 4: Seizure Management

  • Control seizures with benzodiazepines as first-line therapy 1
  • If benzodiazepines ineffective, use phenobarbital or phenytoin 1
  • Physostigmine is NOT recommended except for life-threatening symptoms unresponsive to other therapies, and only in consultation with poison control 1

Step 5: Refractory Cases

  • Consider ECMO for refractory shock unresponsive to pharmacological support 4
  • Hemoperfusion may benefit acute refractory cardiovascular instability in rare instances 1
  • Hemodialysis, peritoneal dialysis, exchange transfusions, and forced diuresis are generally ineffective 1

Critical Pitfalls to Avoid

  • Do not rely on plasma drug level monitoring to guide management - clinical presentation and ECG findings are paramount 1
  • Do not discharge patients after only brief observation - fatal dysrhythmias can occur late, and most deaths involved inadequate GI decontamination 1
  • Combined overdoses enhance toxic effects - doxepin with other CNS depressants (benzodiazepines, neuroleptics) increases risk of severe complications and prolonged coma 3, 4, 2
  • Patients with minor sedation and normal QRS width can still develop major complications - maintain high index of suspicion 5
  • Contact poison control center (1-800-222-1222 in US) for current treatment guidance as management is complex and evolving 1

Post-Resuscitation Care

  • Psychiatric referral is appropriate as overdose is often deliberate and patients may attempt suicide by other means during recovery 1
  • Extended monitoring required if any toxicity signs develop during initial 6-hour observation period 1

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.